RR

Rana Ranvir Singh

Active Director Director DIN 02689267
DIN 02689267 First appointment Jul 2009 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Jul 2009
Shareholding value •••• Premium profile

About Rana Ranvir Singh

Data last updated:

Rana Ranvir Singh is a Director at Agrani Homes Private Limited (since 2022) and Director at Agrani Pharmaceutical Private Limited (since 2016). The companies operate in Real Estate and Construction and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹15.56 Cr; the largest is Agrani Homes Private Limited at ₹15.23 Cr (FY 2018). Earlier, Rana Ranvir Singh was a Director at Janani Sri Construction Private Limited (from 2013) and Director at Samriddhi Green Homes Private Limited (from 2013) and 3 more.

DIN 02689267
Primary Designation Director
Industry Real Estate and Construction
First Appointment 17 Jul 2009
Oldest Company Age 17 yrs
Largest company Agrani Homes Private Limited · ₹15.23 Cr (FY 2018)
Combined revenue ₹15.56 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agrani Homes Private Limited U45400BR2011PTC016646
Director25 Feb 20222011₹15.23 Cr (FY 2018)Active
Director04 Mar 20162016₹33.8 Lakh (FY 2018)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Apr 20132013Strike Off
Director08 Aug 20132013Strike Off
Director17 Jul 20092009Strike Off
Director26 Jun 20142013₹21.2 Lakh (FY 2018)Strike Off
Osaka Trading Private Limited U51909HR2020PTC089995
Director10 Oct 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Agrani Pharmaceutical Private Limited
Janani Sri Construction Private Limited
Samriddhi Green Homes Private Limited
Agrani Homes Private Limited
Premium access

Shareholding and investment profile for Rana Ranvir Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rana Ranvir Singh

Rana Ranvir Singh currently holds 2 directorships: Agrani Homes Private Limited (Director, since 25 Feb 2022, revenue ₹15.23 Cr (FY 2018)); Agrani Pharmaceutical Private Limited (Director, since 04 Mar 2016, revenue ₹33.8 Lakh (FY 2018)).

Rana Ranvir Singh was first appointed on 17 Jul 2009 as Director at Singh Shresta Construction Private Limited. The most recent appointment on record is 25 Feb 2022 at Agrani Homes Private Limited.

The 2 current companies of Rana Ranvir Singh that report revenue have a combined latest revenue of ₹15.56 Cr: Agrani Homes Private Limited ₹15.23 Cr (FY 2018); Agrani Pharmaceutical Private Limited ₹33.8 Lakh (FY 2018).

Rana Ranvir Singh held 5 earlier board appointments: Janani Sri Construction Private Limited (Director, from 08 Apr 2013); Samriddhi Green Homes Private Limited (Director, from 08 Aug 2013); Singh Shresta Construction Private Limited (Director, from 17 Jul 2009); Agrani Homes Real Marketing Private Limited (Director, from 26 Jun 2014); Osaka Trading Private Limited (Director, from 10 Oct 2020).

The current boards of Rana Ranvir Singh's companies include Alok Kumar (Agrani Homes Private Limited), Suraj Kumar (Agrani Homes Private Limited), Padum Singh (Agrani Pharmaceutical Private Limited), Vijaya Raj Laxmi (Agrani Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available